{"entity": "journal", "iuid": "2b479d22329d4835ae043112213bc8bf", "timestamp": "2026-07-14T03:35:24.526Z", "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/journal/Oral%20Dis.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/journal/Oral%20Dis"}}, "title": "Oral Dis", "issn": "1601-0825", "issn-l": "1354-523X", "publications_count": 2, "publications": [{"entity": "publication", "iuid": "2a1acd7bde6d48858bd09f9a3fba20f2", "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/publication/2a1acd7bde6d48858bd09f9a3fba20f2.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/publication/2a1acd7bde6d48858bd09f9a3fba20f2"}}, "title": "Effects of labial adhesion on maxillary arch dimensions and nasolabial esthetics in cleft lip and palate: a systematic review.", "authors": [{"family": "Thierens", "given": "Lam", "initials": "L"}, {"family": "Brusselaers", "given": "N", "initials": "N"}, {"family": "De Roo", "given": "Nmc", "initials": "N"}, {"family": "De Pauw", "given": "Gam", "initials": "G"}], "type": "journal article", "published": "2017-10-00", "journal": {"title": "Oral Dis", "issn": "1601-0825", "volume": "23", "issue": "7", "pages": "889-896", "issn-l": "1354-523X"}, "abstract": "Labial adhesion is a preliminary surgical lip approximation used in the early management of unilateral and bilateral cleft lip and palate. Our objective was to evaluate its effects on the maxillary arch dimensions and nasolabial esthetics by means of a systematic review. The literature search (1955-2016) was based on MEDLINE via PubMed, Web of Science, EMBASE, and the Cochrane Library. Studies with labial adhesion as a single preliminary step for definitive lip closure, in combination with nasoalveolar molding or in combination with infant orthopedics were considered eligible. Fifteen articles were identified (1978-2015), including 587 patients who underwent labial adhesion. Reduction in alveolar cleft width was between 60.9% and 100% in unilateral cases and between 47.5% and 100% in bilateral cases. Reduction in palatal cleft width was between 28.4% and 59.8% in unilateral cases and between 37.5% and 50.5% in bilateral cases. No conclusive results could be drawn about the effect on nasolabial esthetics. This systematic review comprises the available literature of the last 50\u00a0years about labial adhesion. It showed reduction of alveolar and palatal cleft width after a treatment with labial adhesion with or without infant orthopedics. The treatment effect on nasolabial esthetics, especially in the long term, remains unclear.", "doi": "10.1111/odi.12613", "pmid": "27878905", "labels": {"Affiliated researcher": null}, "xrefs": [], "notes": [], "created": "2018-12-05T12:52:26.163Z", "modified": "2018-12-05T12:52:26.182Z"}, {"entity": "publication", "iuid": "c968597647cc4fdabef693ee191760e7", "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/publication/c968597647cc4fdabef693ee191760e7.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/publication/c968597647cc4fdabef693ee191760e7"}}, "title": "Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.", "authors": [{"family": "Fung", "given": "Ppl", "initials": "P"}, {"family": "Bedogni", "given": "G", "initials": "G"}, {"family": "Bedogni", "given": "A", "initials": "A"}, {"family": "Petrie", "given": "A", "initials": "A"}, {"family": "Porter", "given": "S", "initials": "S"}, {"family": "Campisi", "given": "G", "initials": "G"}, {"family": "Bagan", "given": "J", "initials": "J"}, {"family": "Fusco", "given": "V", "initials": "V"}, {"family": "Saia", "given": "G", "initials": "G"}, {"family": "Acham", "given": "S", "initials": "S"}, {"family": "Musto", "given": "P", "initials": "P"}, {"family": "Petrucci", "given": "M T", "initials": "MT"}, {"family": "Diz", "given": "P", "initials": "P"}, {"family": "Colella", "given": "G", "initials": "G"}, {"family": "Mignogna", "given": "M D", "initials": "MD"}, {"family": "Pentenero", "given": "M", "initials": "M"}, {"family": "Arduino", "given": "P", "initials": "P"}, {"family": "Lodi", "given": "G", "initials": "G"}, {"family": "Maiorana", "given": "C", "initials": "C"}, {"family": "Manfredi", "given": "M", "initials": "M"}, {"family": "Hallberg", "given": "P", "initials": "P"}, {"family": "Wadelius", "given": "M", "initials": "M"}, {"family": "Takaoka", "given": "K", "initials": "K"}, {"family": "Leung", "given": "Y Y", "initials": "YY"}, {"family": "Bonacina", "given": "R", "initials": "R"}, {"family": "Schi\u00f8dt", "given": "M", "initials": "M"}, {"family": "Lakatos", "given": "P", "initials": "P"}, {"family": "Taylor", "given": "T", "initials": "T"}, {"family": "De Riu", "given": "G", "initials": "G"}, {"family": "Favini", "given": "G", "initials": "G"}, {"family": "Rogers", "given": "S N", "initials": "SN"}, {"family": "Pirmohamed", "given": "M", "initials": "M"}, {"family": "Nicoletti", "given": "P", "initials": "P"}, {"family": "GENVABO Consortium", "given": "", "initials": ""}, {"family": "Fedele", "given": "S", "initials": "S"}], "type": "journal article", "published": "2017-05-00", "journal": {"title": "Oral Dis", "issn": "1601-0825", "volume": "23", "issue": "4", "pages": "477-483", "issn-l": "1354-523X"}, "abstract": "Osteonecrosis of the jaw (ONJ) is a potentially severe adverse effect of bisphosphonates (BP). Although the risk of ONJ increases with increasing duration of BP treatment, there are currently no reliable estimates of the ONJ time to onset (TTO). The objective of this study was to estimate the TTO and associated risk factors in BP-treated patients.\n\nRetrospective analysis of data from 22 secondary care centres in seven countries relevant to 349 patients who developed BP-related ONJ between 2004 and 2012.\n\nThe median (95%CI) TTO was 6.0 years in patients treated with alendronate (n\u00a0=\u00a088) and 2.2\u00a0years in those treated with zoledronate (n\u00a0=\u00a0218). Multivariable Cox regression showed that dentoalveolar surgery was inversely associated, and the use of antiangiogenics directly associated, with the TTO in patients with cancer treated with zoledronate.\n\nThe incidence of ONJ increases with the duration of BP therapy, with notable differences observed with respect to BP type and potency, route of administration and underlying disease. When data are stratified by BP type, a time of 6.0 and 2.2\u00a0years of oral alendronate and intravenous zoledronate therapy, respectively, is required for 50% of patients to develop ONJ. After stratification by disease, a time of 5.3 and 2.2\u00a0years of BP therapy is required for 50% of patients with osteoporosis and cancer, respectively, to develop ONJ. These findings have significant implications for the design of future clinical studies and the development of risk-reduction strategies aimed at either assessing or modulating the risk of ONJ associated with BP.", "doi": "10.1111/odi.12632", "pmid": "28039941", "labels": {"Affiliated researcher": null}, "xrefs": [], "notes": [], "created": "2018-12-05T11:04:47.532Z", "modified": "2018-12-05T11:04:47.567Z"}], "created": "2018-12-05T11:04:47.547Z", "modified": "2020-11-27T13:12:56.127Z"}